Abiomed Inc (ABMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 06-2021 | 03-2021 | 12-2020 | 09-2020 | 06-2020 | |
| Sales | 252,585 | 241,245 | 231,663 | 209,764 | 164,850 |
| Cost of Goods | 45,188 | 46,078 | 41,110 | 38,736 | 35,983 |
| Gross Profit | 207,397 | 195,167 | 190,553 | 171,028 | 128,867 |
| Operating Expenses | 256,870 | 132,441 | 119,312 | 110,428 | 95,784 |
| Operating Income | -49,285 | 62,804 | 71,351 | 61,336 | 34,066 |
| Other Income | 39,935 | 10,690 | 9,384 | 11,579 | 27,010 |
| Pre-tax Income | -9,350 | 73,494 | 80,735 | 72,915 | 61,076 |
| Income Tax | 17,175 | 16,638 | 18,867 | 10,702 | 16,488 |
| Net Income Continuous | -26,525 | 56,856 | 61,868 | 62,213 | 44,588 |
| Net Income | $-26,525 | $56,856 | $61,868 | $62,213 | $44,588 |
| EPS Basic Total Ops | -0.59 | 1.26 | 1.37 | 1.38 | 0.99 |
| EPS Basic Continuous Ops | -0.59 | 1.26 | 1.37 | 1.38 | 0.99 |
| EPS Diluted Total Ops | -0.59 | 1.25 | 1.35 | 1.36 | 0.98 |
| EPS Diluted Continuous Ops | -0.59 | 1.24 | 1.35 | 1.36 | 0.98 |
| EPS Diluted Before Non-Recurring Items | 1.10 | 1.24 | 1.17 | N/A | N/A |
| EBITDA(a) | $-42,378 | $69,630 | $77,485 | $66,993 | $39,546 |